by Peter Ciszewski | Oct 25, 2021
Daniel DeAngelo, MD, PhD, Chief, Division of Leukemia, Dana-Farber Cancer Institute, discusses treatment options available for systemic mastocytosis (SM). SM is a rare, hematologic disorder most often caused by a mutation in the KIT D816V gene. The disorder is...
by Peter Ciszewski | Oct 25, 2021
Evanthia Bernitsas, MD, of the Department of Neurology at Wayne State University School of Medicine, gives an overview of neuromyelitis optica spectrum disorder (NMOSD) and discusses how the disease affects certain race populations differently. As Dr. Bernitsas...
by Peter Ciszewski | Oct 25, 2021
Nina Shah, MD, Hematologist from the University of California, San Francisco, discusses preclinical data demonstrating that a subset of human natural killer (NK) cells that lack expression of FcεRIγ (g-NK cells) enhance the efficacy of monoclonal antibody...
by Peter Ciszewski | Oct 24, 2021
Lauren Pinter-Brown, MD, Clinical Professor of Hematology/Oncology, University of California Irvine and Director of the Cutaneous Lymphoma Foundation, discusses what physicians should know about cutaneous T-cell lymphoma (CTCL). CTCL belongs to the non-Hodgkin...
by Peter Ciszewski | Oct 22, 2021
Kelly Heger, Founder of the AADC Family Network and mother and caregiver of Jillian Heger, who lives with aromatic L-amino acid decarboxylase (AADC) deficiency, describes Jillian’s diagnostic journey. Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare...
